In roughly three weeks a petition calling on New Jersey Governor Chris Christie to sign a bill adding post traumatic stress disorder as a qualifying medical cannabis condition has over 17,000 signatures.
"On August 1st New Jersey's full legislature gave approval to Assembly Bill 457 which would add post traumatic stress disorder (PTSD) as a qualifying medical cannabis condition. The vote in the Senate was 29 to 9; the vote in the Assembly was 56 to 13", states the petition. "Now, the measure sits on the desk of Governor Chris Christie, who has the option of signing it into law, allowing it to become law without his signature, or vetoing it."
It continues; "We are calling Governor Christie to quickly sign it into law, allowing those suffering from the ailment to use a medicine that research has continually shown is beneficial."
The petition points to two recent studies; a government-funded study released in 2014 using human trials which found that "the cannabinoid system may serve as a promising target for innovative intervention strategies (e.g. pharmacological enhancement of exposure-based therapy) in PTSD and other fear learning-related disorders," and a 2015 study published by the National Institute of Health, which found a "pharmacologic rationale for the use of cannabinoids to manage the three core PTSD symptom clusters: reexperiencing, avoidance and numbing, and hyperarousal."
If Assembly Bill 457 becomes law New Jersey would join Michigan, California, Illinois, Connecticut, Delaware, Maine, Massachusetts, New Mexico, Arizona, Washington, Rhode Island and Oregon as states where those suffering from PTSD can legally use medical cannabis.